In 20 South African clinics, people with advanced HIV will receive a simple urine test for tuberculosis before starting antiretroviral therapy, with results available on the spot. This matters because tuberculosis is the leading cause of death in the first months of HIV treatment, yet standard TB tests often fail in people with HIV. The resulting diagnostic delays mean patients die while waiting for treatment. The study tests whether a low-cost algorithm—using a new urine test, weight, height, and a blood test for anaemia—can quickly identify who needs TB treatment first, then start ART sooner. If the approach reduces six-month death rates compared to routine care, clinics in low-resource settings could adopt this strategy immediately. The tests are inexpensive, require no complex lab equipment, and give results within minutes. That could change how thousands of clinics worldwide manage the deadly intersection of HIV and TB, cutting early deaths without expensive infrastructure upgrades.
View original technical description
Treatment for HIV (antiretroviral therapy, or ART), has greatly reduced death rates among people with HIV worldwide. However in low-resource settings, death rates continue to be high even for people taking ART, particularly in the first few months on treatment. Tuberculosis (TB) is the most important cause of these early deaths, and people who are due to start ART are recommended to be screened for TB first. However, TB is hard to diagnose because the tests which are most widely available do not work well for people with HIV. As a result, people with HIV may have to go through lots of tests for TB, which delays the start of TB treatment; it also delays the start of ART. Both of these delays increase the risk that the patient dies. We propose a study to try to reduce this high death rate. In 20 primary care clinics in South Africa, we will enrol people with advanced HIV who have come to start ART to our study. In 10 of the clinics (intervention), selected at random, we will use simple, inexpensive tests (a new urine test for TB, weight and height, and a blood test for anaemia) which can be done on site with immediate results, to identify those patients who are at highest risk of having TB, and of dying early. People who are high risk will start TB treatment straight away, then ART as soon as possible afterwards; people who are low TB risk will start ART straight away. People with medium TB risk will be given antibiotics while a chest X-ray and sputum (spit) test for TB are done, and will come back after a week to decide if they should start TB treatment followed by ART, or just start ART. At the other 10 (control) clinics, patients will be looked after in the normal way, following national guidelines. We will follow all patients up for 6 months. We will compare the death rate at 6 months in the 10 intervention clinics, using our new approach, to death rates in the 10 control clinics, using the routine approach. If our new approach reduces the death rate, clinics throughout low resource settings could use this low-cost strategy to save lives among people with HIV.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know